Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?

Area of Science:

• Immunology
• Oncology
• Vaccinology

Background:

• Vaccines are effective against viral infections and some virally mediated cancers.
• The immune system's role in tumor surveillance is established in animal models.
• Preventing human cancers without a viral cause using the immune system remains a challenge.

Purpose of the Study:

• To explore immune-based strategies for preventing human cancers, particularly those without a known viral etiology.
• To investigate the potential of targeting the premalignant phase of cancer development.
• To address the challenges posed by immune suppression in preneoplastic lesions.

Main Methods:

• Review of existing literature on host immune response in human premalignancy.
• Analysis of studies on T cell exhaustion and immune-suppressive factors in preneoplastic states.
• Consideration of integrating early detection with immune prevention strategies.

Main Results:

• Premalignant lesions are immunogenic, suggesting potential for immune-based prevention.
• Immune-suppressive factors and T cell exhaustion are present in many preneoplastic states.
• Personalized approaches based on immune response status are needed.

Conclusions:

• Immune-based cancer prevention strategies are promising but require further development for human application.
• Targeting the premalignant phase offers a window for intervention.
• Linking early detection with personalized immune prevention is essential for future success.